Medicare Pays Insurers $16 B for Drug Plans: What’s Behind the Surge
Why $16 B in Medicare Reconciliation Payments Matters Each year Medicare reconciles the cost gap between what insurers projected for Part D drug plans and what they actually spent. When costs exceed projections, the federal government pours money into insurers to keep the market stable. In the most recent cycle, that infusion topped a record $16 billion—a clear … Read more